NOV (NOV)
(Delayed Data from NYSE)
$12.66 USD
-0.03 (-0.24%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $12.66 0.00 (0.00%) 4:36 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, NOV Inc. has a market cap of $4.71B, which represents its share price of $12.69 multiplied by its outstanding shares number of 371.36M. As a mid-cap company, NOV's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NOV 12.66 -0.03(-0.24%)
Will NOV be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NOV
Here's Why Investors Should Consider Selling NOV Stock Now
NOV Secures Key Contract for Argentina's First FLNG Project
NOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nov Inc. (NOV) Down 1.2% Since Last Earnings Report: Can It Rebound?
NOV Stock Drops 19% in the Past Six Months: Time to Hold or Exit?
NOV Q2 Earnings Miss, Revenues Beat Estimates, Both Decrease Y/Y
Other News for NOV
Midday Fly By: Apple new F1 broadcast partner, CSX reports Q3 beat
50 Day Moving Average Resistance appears for NOV after 0.94% move
J.P. Morgan Reaffirms Their Buy Rating on Novo Nordisk (0QIU)
Bernstein Sticks to Their Buy Rating for Novo Nordisk (0QIU)
6 Energy Stocks Lighting Up The Value Leaderboard